CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

BACKGROUND: Cytokeratin 19, and its soluble fragment CYFRA, have been studied as markers that may be associated with response to therapy and survival in NSCLC. As a prospective correlative study of CALGB 30203, a randomized phase II trial of carboplatin/gemcitabine with eicosanoid modulators (celeco...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thorac Oncol
Auteurs principaux: Edelman, Martin J., Hodgson, Lydia, Rosenblatt, Paula Y., Christenson, Robert H., Vokes, Everett, Wang, Xiaofei, Kratzke, Robert
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541770/
https://ncbi.nlm.nih.gov/pubmed/22425913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31824a8db0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires